英文名称 | 中文名称 | CAS | MF |
(E)-N-(4-bromo-3-methylphenyl)-3-(4-chloro-3-nitrophenyl)-2-propenamide
|
|
|
|
(E)-N-(4-bromo-3-methylphenyl)-3-(4-ethoxyphenyl)-2-propenamide
|
|
|
|
(2E)-N-(2-BROMOPHENYL)-2-(HYDROXYIMINO)ACETAMIDE
|
|
|
C8H7BrN2O2
|
(2E)-N-(2-BROMOPHENYL)-2-(HYDROXYIMINO)ACETAMIDE
|
|
101080-38-0
|
C8H7BrN2O2
|
(E)-N-(4-BROMO-3-METHYLPHENYL)-3-[4-(METHYLSULFANYL)PHENYL]-2-PROPENAMIDE
|
|
478258-02-5
|
C17H16BrNOS
|
(E)-N-(4-BROMO-3-METHYLPHENYL)-3-(3-PHENOXYPHENYL)-2-PROPENAMIDE
|
|
478258-27-4
|
C22H18BrNO2
|
(2E)-N-(4-bromophenyl)-2-(3,3-dimethyl-2,4-dihydroisoquinolin-1-yliden e)acetamide
|
|
170658-12-5
|
C19H19BrN2O
|
(1E)-N-(4-BROMOPHENYL)-2-OXOPROPANEHYDRAZONOYL CHLORIDE
|
|
|
C9H8BrClN2O
|
(2E)-N-(4-Bromophenyl)-3-ethoxy-2-propenamide
|
|
327058-51-5
|
C11H12BrNO2
|
(E)-N-(4-Bromophenyl)-3-phenyl-2-propenamide
|
|
134430-89-0
|
C15H12BrNO
|
(E)-N-(4-bromo-3-methylphenyl)-3-(4-isobutylphenyl)-2-propenamide
|
|
|
|
(E)-N-(2-(4-BROMOPHENYL)-3-(DIMETHYLAMINO)ALLYLIDENE)-N-METHYLMETHANAMINIUM HEXAFLUOROPHOSPHATE
|
|
848757-79-9
|
C13H18BrF6N2P
|
Naftifine hydrochloride
|
盐酸萘替芬
|
65473-14-5
|
C21H22ClN
|
Enciprazine
|
恩西拉嗪
|
68576-86-3
|
C23H32N2O6
|
enbucrilate
|
恩布酯
|
6606-65-1
|
C8H11NO2
|
Elvucitabine-13C,15N2
|
|
|
C9H10FN3O3
|
Endamoeba medium
|
内阿米巴培养基粉末
|
|
|
endA protein
|
|
|
|
EMM-LG-AGAR
|
|
|
|
EMM-LG
|
|
|
|
(E)-N-butyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-3-phenyl-prop-2-e namide hydrochloride
|
|
171261-31-7
|
C21H31ClN2O
|
EM-80 (NATURAL VITAMIN E)
|
|
|
|
(2E)-N-(4-BUTYLPHENYL)-2-(HYDROXYIMINO)ACETAMIDE
|
|
18331-68-5
|
C12H16N2O2
|
(E)-N-butyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-en-3-yl)-3-phenyl-pro p-2-enamide, oxalic acid
|
|
171261-25-9
|
C23H30N2O5
|
(2E)-N-(4-BUTYLPHENYL)-2-(HYDROXYIMINO)ACETAMIDE
|
|
|
C12H16N2O2
|
(3E)-N-Butylpent-3-Enamide
|
|
|
|
(3E)-N-Butylhex-3-Enamide
|
|
|
|
(E)-N-(5-(4-BUTOXY-3-METHOXYBENZYLIDENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)-4-METHOXYBENZAMIDE
|
|
|
C23H24N2O5S2
|
(E)-N-({2-[4-(butyrylamino)benzoyl]hydrazino}carbothioyl)-3-(4-fluorophenyl)-2-propenamide
|
|
|
C21H21FN4O3S
|
(E)-N-({2-[4-(butyrylamino)benzoyl]hydrazino}carbothioyl)-3-(2-furyl)-2-propenamide
|
|
|
C19H20N4O4S
|
(E)-N-(4-Butylphenyl)-3-(3,4-dihydroxyphenyl)propenamide
|
|
|
|
(E)-N-Butyl-3-(3,4-dihydroxyphenyl)propenamide
|
|
|
|
(E)-N-Butyl-2-buten-1-amine
|
|
62337-86-4
|
|
END CAP ADAPTER
|
|
|
|
END CAP REUSE PROGRAM
|
|
|
|
END CAPPED AND PARTIALLY END CAPPED BROMINATED EPOXY OLIGOMER
|
|
139638-58-7
|
|
EMM MEDIUM
|
|
|
|
EmmL9 protein
|
|
|
|
EmmL55 protein
|
|
|
|
END CONVERSION MIX
|
|
|
|
end-control adhesive tape FD-50
|
FD-50端控胶带
|
|
|
(E)-N-Decyl-3-(3,4-dihydroxyphenyl)propenamide
|
|
|
|
(E)-N-Decyl-3-(3,4-dihydroxyphenoxy)propenamide
|
|
|
|
EMM NO NITROGEN
|
|
|
|
EMM NO PHOSPHATES
|
|
|
|
encore protein
|
|
|
|
enderpins
|
|
|
|
encorat
|
|
|
|
ENDERE S
|
甘油松香树脂136
|
8050-31-5
|
C3H8O3
|
ENDERE A
|
|
|
|
(E)-N-Desmethyldoxepin hydrochloride
|
|
|
|
END FITTING W/FRIT FOR 21.5MM
|
|
|
|
End-fitting adapter for large columns
|
用于大柱子的接头
|
|
|
ENC-1 protein
|
|
|
|
Emm2 protein
|
|
|
|
(E)-N-[2-(β-D-Glucopyranosyloxy)ethyl]-3-methylthiopropenamide
|
|
|
|
(E)-N-{4-[(diallylamino)sulfonyl]phenyl}-3-(2-thienyl)-2-propenamide
|
|
|
C19H20N2O3S2
|
(E)-N-{4-[(diallylamino)sulfonyl]phenyl}-3-phenyl-2-propenamide
|
|
|
C21H22N2O3S
|
(E)-N-{4-[(diallylamino)sulfonyl]phenyl}-3-(4-fluorophenyl)-2-propenamide
|
|
|
C21H21FN2O3S
|
(E)-N-{4-[(diallylamino)sulfonyl]phenyl}-3-(4-methylphenyl)-2-propenamide
|
|
|
C22H24N2O3S
|
(E)-N-{4-[(diallylamino)sulfonyl]phenyl}-3-(4-methoxyphenyl)-2-propenamide
|
|
|
C22H24N2O4S
|
(2E)-N-(3,4-DICHLOROPHENYL)-2-(HYDROXYIMINO)ACETAMIDE
|
|
6662-53-9
|
C8H6Cl2N2O2
|
(E)-N'-(3,4-Dichlorobenzyloxycarbamoyl)-N,N-dimethylformimidamide
|
|
|
C11H13Cl2N3O2
|
(E)-N-(3,5-dichlorophenyl)-3-(3,4-dimethoxyphenyl)-2-propenamide
|
|
|
C17H15Cl2NO3
|
(E)-N-(3,5-dichlorophenyl)-3-(4-fluorophenyl)-2-propenamide
|
|
|
C15H10Cl2FNO
|
(E)-N-(3,5-dichlorophenyl)-3-(1-naphthyl)-2-propenamide
|
|
|
C19H13Cl2NO
|
(E)-N-(3,4-dichlorophenyl)-3-(4-fluorophenyl)-2-propenamide
|
|
|
C15H10Cl2FNO
|
(E)-N-(3,5-dichlorophenyl)-3-phenyl-2-propenamide
|
|
|
C15H11Cl2NO
|
(E)-N-(2,4-dichlorophenyl)-3-(1-naphthyl)-2-propenamide
|
|
|
C19H13Cl2NO
|
(E)-N-(3,4-dichlorophenyl)-3-(2-furyl)-2-propenamide
|
|
|
C13H9Cl2NO2
|
(E)-N-(3,4-dichlorophenyl)-3-(1-naphthyl)-2-propenamide
|
|
|
C19H13Cl2NO
|
(E)-N-(3,4-Dichlorobenzyloxycarbamoyl)-N'-methoxyformimidamide
|
|
|
C10H11Cl2N3O3
|
(E)-N-(2,6-Dichlorobenzyloxycarbamoyl)-N'-hydroxyformimidamide
|
|
|
C9H9Cl2N3O3
|
(E)-N-(3,4-DICHLOROBENZYL)-3-[4-(3-FLUOROPROPOXY)PHENYL]-2-PROPENAMIDE
|
|
|
C19H18Cl2FNO2
|
(E)-N-(3,5-dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)-2-propenamide
|
|
|
|
(E)-N-[2-(2,4-dichlorophenoxy)ethyl]-2-butenamide
|
|
|
|
(2E)-N-[2-(2,3-DICHLOROPHENYL)-1,3-BENZOXAZOL-5-YL]-3-PHENYLACRYLAMIDE
|
|
|
C22H14Cl2N2O2
|
(2E)-N-(3,4-DICHLOROPHENYL)-2-(HYDROXYIMINO)ACETAMIDE
|
|
|
C8H6Cl2N2O2
|
(E)-N-(3,4-DICHLOROBENZYL)-3-(3-QUINOLINYL)-2-PROPENAMIDE
|
|
|
C19H14Cl2N2O
|
(1E)-N-(2,4-DICHLOROPHENYL)-2-OXOPROPANEHYDRAZONOYL CHLORIDE
|
|
|
C9H7Cl3N2O
|
(E)-N-(3,4-DICHLOROBENZYL)-3-(4-[(2,4-DICHLOROBENZYL)OXY]PHENYL)-2-PROPENAMIDE
|
|
|
C23H17Cl4NO2
|
(E)-N-(1-(2,4-DICHLOROPHENYL)-4,4-DIMETHYLPENT-1-EN-3-YL)-1-FORMAMIDOCYCLOHEXANECARBOXAMIDE
|
|
|
C21H28Cl2N2O2
|
(E)-N-(2,4-Dichlorobenzyloxycarbamoyl)-N'-methoxyformimidamide
|
|
|
C10H11Cl2N3O3
|
(E)-N-(3,4-Dichlorophenyl)-cinnamamide
|
|
|
|
(E)-N-(2,4-Dichlorobenzyloxycarbamoyl)-N'-hydroxyformimidamide
|
|
|
C9H9Cl2N3O3
|
(E)-N-(2,6-Dichlorobenzyloxycarbamoyl)-N'-methoxyformimidamide
|
|
|
C10H11Cl2N3O3
|
(E)-N'-(2,6-Dichlorobenzyloxycarbamoyl)-N,N-dimethylformimidamide
|
|
|
C11H13Cl2N3O2
|
(E)-N-(3,4-Dichlorobenzyloxycarbamoyl)-N'-hydroxyformimidamide
|
|
|
C9H9Cl2N3O3
|
(E)-N-[4-(diethylamino)phenyl]-3-phenyl-2-propenamide
|
|
|
C19H22N2O
|
(E)-N-[4-(diethylamino)phenyl]-3-(1-naphthyl)-2-propenamide
|
|
|
C23H24N2O
|
(E)-N-{4-[(diethylamino)sulfonyl]phenyl}-3-phenyl-2-propenamide
|
|
|
C19H22N2O3S
|
(E)-N-{4-[(diethylamino)sulfonyl]phenyl}-3-(2-furyl)-2-propenamide
|
|
|
C17H20N2O4S
|
(E)-N-{4-[(diethylamino)sulfonyl]phenyl}-3-(4-fluorophenyl)-2-propenamide
|
|
|
C19H21FN2O3S
|
(E)-N-{4-[(diethylamino)sulfonyl]phenyl}-3-(1-naphthyl)-2-propenamide
|
|
|
C23H24N2O3S
|
(E)-N-{4-[(diethylamino)sulfonyl]phenyl}-3-(4-methoxyphenyl)-2-propenamide
|
|
|
C20H24N2O4S
|
(E)-N'-(4-(DIETHYLAMINO)BENZYLIDENE)-2-(5-(NAPHTHALEN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)THIAZOLE-4-CARBOHYDRAZIDE
|
|
|
C29H25F3N6OS
|
(E)-N'-(4-(DIETHYLAMINO)BENZYLIDENE)-2-(5-PHENYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)THIAZOLE-4-CARBOHYDRAZIDE
|
|
|
C25H23F3N6OS
|
(E)-N-(5-(3,4-DIETHOXYBENZYLIDENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)-4-METHOXYBENZAMIDE
|
|
|
C22H22N2O5S2
|
(E)-N-(3,4-difluorophenyl)-3-(4-isobutylphenyl)-2-propenamide
|
|
|
|
(E)-N-(2,4-difluorophenyl)-3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-propenamide
|
|
|
|